Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-Kala-Azar dermal leishmaniasis

4Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Post-kala-azar dermal leishmaniasis is a skin disorder occurring in 5-10% of visceral leishmaniasis patients after treatment with miltefosine,the first-line drug for this skin disorder. We reported a case of acute anterior uveitis,a rare adverse effect, experienced by a patient treated with miltefosine for post-kala-azar dermal leishmaniasis. This adverse effect developed after 15 days of miltefosine consumption, and the patient himself discontinued the treatment. The ophthalmic complication was completely resolved with antibiotics and steroid eye drops. After recovery from the ophthalmic complication, the patient was successfully treated with liposomal amphotericin B for the skin lesions.

Cite

CITATION STYLE

APA

Pandey, K., Pal, B., Topno, R. K., Lal, C. S., Das, V. N. R., & Das, P. (2021). Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-Kala-Azar dermal leishmaniasis. Revista Da Sociedade Brasileira de Medicina Tropical, 54, 1–3. https://doi.org/10.1590/0037-8682-0208-2020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free